Calvert Research

Calvert Research Awarded Federal Grants Totaling Approximately $245,000 to Support Further Development of Its Age-Related Macular Degeneration Drug Candidate

Calvert Research, LLC announced today that one of the Company’s therapeutic development programs (T1-1081) qualified to receive federal grant funding totaling approximately $245,000 under the Patient Protection and Affordable Care Act of 2010 (“The ACT”), which will be used to... - November 17, 2010